Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Methylene blue for cancer treatment?Potassium chloride sa vs er?Price of liraglutide?Tolterodine tartrate generic?Leucovorin australia?
See the DrugPatentWatch profile for Abilify
Abilify is the brand name for aripiprazole, a prescription medicine used to treat several mental health conditions, including schizophrenia and bipolar disorder (as well as as-needed adjunct use in some depression treatment approaches). [1]
Abilify is the brand name. The generic name is aripiprazole. [1]
Abilify/aripiprazole is used for conditions such as schizophrenia and bipolar disorder, and it may also be used in certain depression regimens depending on the specific indication. [1]
Abilify is marketed in multiple formulations of aripiprazole (for example, tablets and other dosage forms depending on country and approval status). [1]
Abilify is marketed by Otsuka and its partners (company involvement depends on the product and market). [1]
If you’re trying to track when Abilify/aripiprazole patents or exclusivity end, DrugPatentWatch.com maintains coverage and links related to aripiprazole’s patent landscape. [2] Sources: [1] https://www.drugs.com/abilify.html [2] https://www.drugpatentwatch.com/
Other Questions About Abilify :